Despite the clear major contribution of hyperlipidemia to the prevalence of cardiovascular disease in the developed world, the direct effects of lipoproteins on endothelial cells have remained obscure and are under debate. Here we report a previously uncharacterized mechanism of vessel growth modulation by lipoprotein availability. Using a genetic screen for vascular defects in zebrafish, we initially identified a mutation, stalactite (stl), in the gene encoding microsomal triglyceride transfer protein (mtp), which is involved in the biosynthesis of apolipoprotein B (ApoB)-containing lipoproteins. By manipulating lipoprotein concentrations in zebrafish, we found that ApoB negatively regulates angiogenesis and that it is the ApoB protein particle, rather than lipid moieties within ApoB-containing lipoproteins, that is primarily responsible for this effect. Mechanistically, we identified downregulation of vascular endothelial growth factor receptor 1 (VEGFR1), which acts as a decoy receptor for VEGF, as a key mediator of the endothelial response to lipoproteins, and we observed VEGFR1 downregulation in hyperlipidemic mice. These findings may open new avenues for the treatment of lipoprotein-related vascular disorders.
We identified a zebrafish mutant, which we named stalactite (stl), with excessive sprouting angiogenesis, in a Tg(fli1:eGFP) y1 (refs. 1, 2) transgenic-based forward genetic screen for vascular-specific mutations. stl mutants have ectopic angiogenic segments that extend ventrally from the subintestinal vessels (SIVs) (Fig. 1a,b) , a vascular bed that initially forms bilaterally over the dorsal-lateral aspect of the large zebrafish yolk cell (Supplementary Fig. 1) . A quantitative analysis ( Supplementary Fig. 1 ) revealed both greater numbers and longer lengths of ventral SIV sprouts in stl mutants (Fig. 1c) compared to their wild-type (WT) siblings. At slightly later stages of development, we also found excessive angiogenic branching in the dorsal part of the intersegmental vessels (ISVs) in stl mutants compared to their WT siblings (Fig. 1d,e) . We counted endothelial nuclei in the yolk areas of WT and stl; Tg(fli1:neGFP) y7 embryos to determine whether formation of ectopic sprouts in stl mutants involves overproliferation of endothelial cells. The total number of endothelial cells in the yolk area was 42% higher in stl mutants than in their WT siblings, with excess cells being found exclusively in the ectopic ventral sprouts of the mutant embryos (Fig. 1f,g ). stl mutants also had defects in yolk absorption ( Supplementary Fig. 1 ), and stl mutant larvae died by approximately 6 days post fertilization (dpf).
To examine the molecular nature of the stl phenotype, we positionally cloned the defective locus. We genetically mapped the mutation to an interval in linkage group 1 that contains the gene encoding microsomal triglyceride transfer protein (mtp). Sequence analysis of mtp complementary DNA (cDNA) from stl mutants and their wild-type siblings revealed a change in a conserved leucine residue (Leu475) to a proline in the mutants (Supplementary Fig. 2) . MTP, an intraluminal protein found within the endoplasmic reticulum of the liver and intestine, is required for the assembly and secretion of proatherogenic, ApoB-containing lipoproteins such as chylomicrons, very-lowdensity lipoproteins and low-density lipoproteins (LDLs) 3 . After their assembly into mature particles, ApoB-containing lipoproteins are secreted into the blood and lymph stream. Although the MTP-ApoB pathway was originally thought to be unique to the liver and intestine, the findings that the mouse yolk sac expresses Mtp and that mice homozygous for an Mtp gene disruption die at embryonic day 10.5 (ref. 4) underscores the key role of the synthesis and secretion of ApoBcontaining lipoproteins during early embryogenesis. The yolk syncytial layer (YSL) of zebrafish (the functional counterpart of the yolk sac of higher vertebrates) expresses mtp starting at the gastrula stage 5 and forms ApoB-related lipoproteins, which enter the circulatory ApoB-containing lipoproteins regulate angiogenesis by modulating expression of VEGF receptor 1 system and deliver nutrient lipids to the tissues [6] [7] [8] . As in mice and humans, zebrafish MTP is involved in lipoprotein assembly in the YSL and is also found at later stages of development in the intestine and liver 5, 9 . In addition, zebrafish have structural and functional homologs of mammalian ApoAI, ApoCII, ApoE, phospholipase A2 (PLA2) and lipoprotein lipase (LPL) 10, 11 .
Four additional lines of evidence confirm that a mutation in mtp is responsible for the stl phenotype. First, injection of antisense morpholino oligonucleotides targeting mtp 6 reproducibly phenocopied the angiogenesis and yolk absorption phenotypes seen in stl mutants ( Supplementary Fig. 3a,b,d) . Second, injection of mtp mRNA into stl mutants suppressed ectopic sprouting, and mRNA-rescued larvae survived for at least 10 dpf (Supplementary Fig. 3a,c,e) . Third, downregulation of apoB using apoB morpholino oligonucleotides led to ectopic SIV branching that was reminiscent of that seen in the stl mutants (Supplementary Fig. 3f ). However, we did not observe this proangiogenic response upon downregulation of apoA1 (Supplementary Fig. 3g ). Finally, reduction of LDL concentrations in WT embryos using atorvastatin 12 efficiently phenocopied the phenotype of excess angiogenesis seen in stl mutants (Fig. 1h,i) . Together, these results confirm the specificity of the MTP-ApoB pathway in causing excess angiogenesis.
The restricted expression of the mtp transcript in the yolk syncytium, liver and intestine 5 and the lack of vascular mtp expression (Supplementary Fig. 3h ) strongly suggest that the role of this gene in vessel development is not cell autonomous. To confirm this notion, we injected mtp mRNA into the yolk syncytium of WT and stl mutant zebrafish at the dome stage. As the cytoplasmic bridges between the embryo and the yolk cell are already closed by the 1,000-cell stage 13 (before the dome stage), reagents injected into the yolk cell after this stage are restricted exclusively to the yolk syncytium. As expected for a YSL-specific defect, injection of mtp mRNA at the dome stage yielded efficient rescue of the excessive angiogenesis phenotype in stl mutants (Supplementary Fig. 3e ).
In humans, mutations in MTP are the proximate cause of abetalipoproteinemia [14] [15] [16] , an autosomal-recessive defect in the production of ApoB-containing lipoproteins that results in a virtual absence of LDL in the blood. To confirm that the effects of mtp downregulation on lipoprotein production and secretion are conserved in zebrafish, we stained WT and stl mutant zebrafish larvae with Oil Red O (ORO) 6 . stl mutants had a clear absence of lipids in their vasculature when compared to their WT siblings (Fig. 1j) . To further confirm the lipoprotein-depletion phenotype, we performed a detailed lipid profile analysis of the stl mutants. Taking advantage of the fact that exogenously supplied, radioactively labeled fatty acids are properly processed by zebrafish larvae and are found as expected in the triglyceride fraction 17 , we used thin-layer chromatography to confirm that the concentrations of triglycerides are strongly reduced in stl mutants ( Supplementary Fig. 4 ). We also found reduced concentrations of cholesterol using gas chromatography-mass spectrometry (GC-MS) ( Supplementary Fig. 4) .
To further characterize the effects of lipoproteins on angiogenesis in vivo, we generated a zebrafish model of lipoprotein overload in the circulation by downregulating the apoCII gene 18, 19 . ApoCII is a [21] [22] [23] . We reasoned that whereas morpholino knockdown of apoCII early in development would lead to a global reduction in lipid delivery, the endothelial cells of these morphants would nevertheless be exposed to elevated concentrations of plasma lipoproteins, mimicking the hyperlipidemia seen in APOCII mutant humans. Injection of apoCII morpholino oligonucleotides into Tg(fli1:eGFP) y1 embryos resulted in increased intravascular concentrations of lipoproteins, as assessed by ORO staining at 4 dpf ( Fig. 2a ; compare with Fig. 1j ). This increase was accompanied by a marked reduction in total triglyceride and cholesterol levels ( Supplementary  Fig. 4 ). In contrast to the excess angiogenesis phenotype seen in stl mutants, however, we found no ectopic SIV sprouts in apoCII (Fig. 2b,c ) or lpl morphants ( Supplementary Fig. 4 ), confirming that global lipoprotein starvation per se does not lead to excessive angiogenesis. On the contrary, high lipoprotein concentrations in the circulation of apoCII morphants resulted in a poorly developed vasculature that was characterized by short and partially lumenized ISVs ( Fig. 2d-f ). These results are consistent with previous findings describing premature vascular disease 24 and general endothelial dysfunction 25 under hyperlipoproteinemic conditions in humans 26 .
To further show that the angiogenic phenotypes seen in stl and apoCII morphants result from a direct response of endothelial cells to lipoprotein concentrations and not from alternative cues trigged by fatty-acid depletion, we investigated the ability of exogenously supplied fatty acids to restore a normal vasculature. The addition of short-, intermediate-or long-chain fatty acids to the embryo culture media did not rescue the vascular phenotype of stl mutants (Fig. 2g,h ) or apoCII morphants (Fig. 2i,j and data not shown), even when applied at high concentrations ( Supplementary Fig. 4) , consistent with the notion that the angiogenic phenotypes result from a direct response of the endothelial cells to lipoprotein concentrations.
To elucidate the mechanisms underlying the effects of lipoproteins on vascular growth, we began by searching for endothelial-specific mRNAs whose expression was affected by changes in lipoprotein concentrations. Quantitative real time PCR (Fig. 3a) and in situ hybridization ( Supplementary Fig. 5 ) revealed that vegfr1 mRNA levels were lower in mtp morpholino oligonucleotide-injected embryos than in uninjected siblings at 24 h post fertilization (hpf). This reduction was specific for vegfr1, as we found little change in the levels of vegfr2 or vegfr3 mRNAs or in the mRNA levels of other vascular genes in the mtp morphants ( Fig. 3a and Supplementary Fig. 5 ). VEGFR1 protein concentrations were also strongly downregulated in stl mutants but were substantially upregulated in apoCII morphants, in which endothelial cells face high concentrations of ApoB lipoproteins (Fig. 3b) . We found similar effects on VEGFR1 levels in endothelial cells in vitro. Treatment of cultured human umbilical vein endothelial cells (HUVECs) with LDL elicited an increase in VEGFR1 but not VEGFR2 concentrations (Fig. 3b) . In addition, hyperlipidemic Apoe-or Ldlr-null mice (reviewed in refs. 27,28) also showed increased endothelial-specific Vegfr1 expression compared to control WT mice ( Fig. 3c-e) , confirming conservation of this pathway in higher vertebrates.
Previous studies have shown that VEGFR1 has an inhibitory role in angiogenesis, acting as a 'sink' for the VEGF ligand [29] [30] [31] . Downregulation of vegfr1 by an ATG-blocking morpholino oligonucleotide resulted in excessive sprouting and branching from the Fig. 5 ). We reasoned that if lipoprotein depletion promotes angiogenesis by downregulation of VEGFR1, we should be able to rescue the proangiogenic phenotype of the stl mutants by restoring VEGFR1 expression. Indeed, injection of vegfr1 mRNA into stl mutant embryos suppressed ectopic SIV sprouting (Fig. 3f,g ). Furthermore, siRNA-mediated downregulation of VEGFR1 (Fig. 3h) abolished the ability of cultured HUVECs to respond to LDL levels in both wound-healing and Boyden-chamber (data not shown) assays. The changes in vegfr1 mRNA levels observed in stl mutants (Fig. 3a) and Apoe-null mice (Fig. 3e) could have resulted from either transcriptional regulation or post-transcriptional modifications altering the stability of the vegfr1 transcript. To distinguish between these two possibilities, we took advantage of a transgenic zebrafish line that expresses yellow fluorescent protein (YFP) under the regulation of the vegfr1 promoter 32 . In these animals, YFP expression recapitulates the pattern of endogenous vegfr1 expression 32 . However, the YFP cassette possesses its own 3′ untranslated region (Online Methods); hence, YFP expression would not be subject to post-transcriptional modifications mediated by the 3′ untranslated region of the vegfr1 gene. We hypothesized that if APOB lipoproteins regulate vegfr1 mRNA expression at the transcriptional level, downregulation of mtp will result in a significant decrease in the levels of yfp mRNA. If in turn, vegfr1 downregulation involves alterations in its mRNA stability, the levels of yfp mRNA will remain unchanged upon mtp morpholino oligonucleotide injection. mtp knockdown resulted in a significant (P = 0.0248) decrease in YFP expression (Fig. 3i,j) , providing evidence that ApoB-containing lipoproteins inhibit vegfr1 expression at the transcriptional level. Whether this regulation is direct or indirect remains to be determined.
Because the vascular phenotype of stl mutants was not triggered by global lipid starvation (Fig. 2) , we hypothesized that lowered concentrations of lipoproteins in mutant animals, directly sensed by endothelial cells, exert a proangiogenic response. To test this hypothesis, we first examined whether exogenously supplied LDL could suppress ectopic sprouting in stl mutants when applied intravascularly. Injection of LDL labeled with the lipophilic carbocyanine dye DiI into 2.5-dpf stl mutants resulted in a strong reduction in both the (Fig. 4a,b) , suggesting that circulating lipoproteins can activate antiangiogenic mechanisms in endothelial cells.
To further confirm the cell-autonomous nature of the endothelial response, we designed an in vivo approach to allow for the localized delivery of exogenous ApoB particles in the proximity of angiogenic vessels. Lipoprotein-secreting HEK293 cells cotransfected with vectors encoding the human forms of MTP and ApoB34 (ref. 33) (Supplementary Fig. 6a ) or untransfected HEK293 control cells were transplanted into the perivitelline space on one side of 2.5-dpf stl; Tg(fli1:eGFP) y1 embryos in close proximity to the forming SIVs (Fig. 4c) . ApoB34 is a truncated form of ApoB that has been shown to be properly assembled and secreted in the presence of MTP 33 . We chose to use this construct as it is the shorter form of ApoB whose secretion is MTP dependent. Lipoprotein-secreting cells impeded the migration of endothelial cells and the growth of ectopic sprouts in the area of transplantation (Fig. 4d) . Ectopic SIV sprouting, however, was not affected on the untransplanted side of the same embryos (Fig. 4d) , confirming that the localized transplantation did not result in systemic rescue of the stl phenotype. Non-lipoprotein-secreting cells, in contrast, did not impede endothelial migration or sprouting (Fig. 4d) . Quantitative analysis revealed a much lower amount of endothelial migration onto lipoprotein-producing when compared to non-lipoprotein-producing cells (Fig. 4e and Supplementary  Fig. 6b ). We also found a similar direct inhibitory effect of LDL on the migration of HUVECs and human aortic endothelial cells (HAECs) in vitro using either Boyden-chamber (Supplementary Fig. 7a ) or wound-healing (Supplementary Fig. 7b ) assays. We observed these effects even at concentrations of LDL that did not affect cell proliferation (Supplementary Fig. 7c) . It is notable, however, that LDL concentrations that are considered pathological in humans (>160 mg dl −1 ) result in endothelial cell death in vitro (ref. 34 (Fig. 4f-i) . Although an intravascular supply of free fatty acids did not rescue the ectopic branching phenotype of the mutants, injection of a delipidated form of ApoB-100 (Online Methods) substantially reduced the number and length of the ectopic angiogenic sprouts (Fig. 4f-i) . ApoB-100 is the full-length form of the endogenous apoB gene, encoding a 550-kDa protein, that is essential for the assembly and secretion of ApoB-containing lipoproteins from the liver (very-low-density lipoprotein, LDL and intermediate-density lipoprotein). These results strongly support the idea that the ApoB protein itself, but not the lipid moieties within the lipoprotein, acts on endothelial cells to regulate angiogenesis.
Endothelial-lipoprotein interactions have direct relevance to atherogenesis, thrombosis and other cardiovascular diseases. The results presented here reveal an intrinsic capacity of ApoB-containing lipoproteins to control vascular growth by regulating the expression of VEGFR1 in endothelial cells (Fig. 4j) .
Previous data has hinted at direct interactions between LDL and VEGF receptors in vitro 35, 36 , but the molecular mechanisms regulating this interplay have remained unclear. Here we show that expression of VEGFR1 is regulated in vivo by the availability of ApoB-containing lipoproteins. Moreover, we show that this regulation is achieved primarily at the transcriptional level. However, the molecular pathways responsible for this regulation are unknown, including which receptors within the endothelial cells mediate the uptake of lipoproteins or provide signals in response to lipoprotein particle abundance. The finding that endothelial cells of Ldlr-null mice express elevated amounts of Vegfr1 highlights the potential role of alternative lipoprotein receptors in mediating the endothelial response.
Recent evidence suggests a potentially crucial role for the nutritional state of tissues in vessel growth [37] [38] [39] . By taking advantage of our new zebrafish models of hypolipidemia and hyperlipidemia, we show that the effects of ApoB-containing lipoproteins on angiogenesis are not trigged by a reduced delivery of fatty acids to tissues or to global lipid starvation, as apoCII deficiency in zebrafish embryos did not phenocopy the vascular phenotype that resulted from the loss of MTP. Furthermore, the high plasma concentrations of triglyceride-rich ApoB-containing lipoproteins in these animals inhibited angiogenesis, as did exogenous delivery of LDL. This effect, however, required the presence of ApoB, as intravascular delivery of a delipidated form of ApoB-100, but not of free fatty acids, efficiently reverted the excessive angiogenesis phenotype of stl mutants. Although we cannot exclude the possibility that the fate of delipidated ApoB in circulation might involve its association with endogenous plasma lipid moieties, our results support the notion that ApoB itself provides the crucial signal for the antiangiogenic effects.
Several pathological conditions involve dramatic alterations in lipoprotein concentrations, resulting in a wide variety of vascularrelated diseases. Our results have uncovered a new mechanism for the regulation of developmental angiogenesis by ApoB-containing lipoproteins that seems to be reactivated during pathological conditions of hyperlipidemia. These findings may provide an explanation for the endothelial dysfunction that precedes the formation of atherogenic plaques, as well as for the impaired collateral vessel growth that is observed in patients with hypercholesterolemia. Furthermore, these findings raise key questions about the potential effects of circulating lipoproteins during tumor-related angiogenesis.
METHoDs
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oNLINE METHoDs
Zebrafish husbandry and transgenic lines. Zebrafish were raised by standard methods 40 and were handled according to the guidelines of the Weizmann Institute Animal Care and Use Committee. The Tg(fli1:eGFP) yl and Tg(fli1: neGFP) y7 (refs. 1,2) lines were previously generated. The Tg(flt1:YFP) hu4624 (ref. 32) line was generated by inserting a cassette of yfp with its own 3′ untranslated region (the simian virus 40 (SV40) late poly(A) region from the plasmid pCS2 + ) and the neo gene conferring neomycin resistance at the translational start of the vegfr1 gene.
Positional cloning. Generation of the lines used for genetic mapping of the stl mutation, the bulk segregant analyses, the genomic DNA isolation and PCR were performed as described elsewhere 41 . Oligonucleotide sequences for Z7573 (5′-TGTTGCACCATATTGTGGCT-3′ and 5′-AGACAAGAAAGGGG TCTGCA-3′), Z26148 (5′-CAACTTTGCGAGTGCTTTCA-3′ and 5′-TGGA GTGGTGTGTGTTGCTT-3′) and Z49706 (5′-TTCGGTATGCACAAA TACGC-3′ and 5′-GTGCAGTTTGCGTCACTTGT-3′) were obtained at http://danio.mgh.harvard.edu/markers/ssr.html (ZV7) and http://www. ensembl.org/Danio_rerio/Info/Index (ZV7). Candidate SSR marker primer pairs 9273 (5′-CTTGGATGGCCTTGGGGAGAGT-3′ and 5′-GGG TGGTTGGGTGTTGTTGTTC-3′), 9606 (5′-GAGCCCACCACACCAT CAG-3′ and 5′-AAAGCCATTCACATTCATAGTAGG-3′) and 9522 (5′-AG GAGGAGTCTGAGGTTC-3′ and 5′-GTAGATGCGCTGGTTTTGATG GTA-3′) were generated using the Zebrafish SSR search website, Massachusetts General Hospital, Charlestown, MA, at http://danio.mgh.harvard.edu/markers/ ssr.html. The primers used for PCR to identify SNPs for positional cloning were designed on the basis of the available zebrafish genomic sequence at http:// www.ensembl.org/Danio_rerio/Info/Index, http://vega.sanger.ac.uk/index. html and http://www.sanger.ac.uk/Projects/D_rerio/WebFPC/zebra/small. shtml. Polymorphism analyses and sequence comparisons were performed using SeqMan alignment software (DNASTAR).
Generation of the pCS2mtpCDS and pCS2vegfr1CDS plasmids. We used the following primers to amplify the full-length coding sequences of zebrafish mtp and vegfr1: mtp: 5′-ATGATGCCGGTTGCCGGACT-3′ and 5′-TTACCAGGCCGGCTCAAAGA-3′; and vegfr1: 5′-GACCAAGAGAATG TTCGATATATTATTTGTG-3′ and 5′-TTAGAAACTGGGGTAAAGAAGAT CGCCTTC-3′. After TOPO (Invitrogen) cloning and sequencing, a Gatewaycompatible (Invitrogen) middle entry clone was generated using Gateway BP clonase (Invitrogen) mediated recombination. The mtp and vegfr1 coding sequences were then transferred into a pCSDest vector using Gateway LR clonase (Invitrogen) mediated reaction to produce the pCSmtpCDS and pCSvegfr1CDS plasmids. After linearization with NotI, the plasmids were used as templates for mRNA synthesis.
Injection of zebrafish embryos. mtp 6 , apoCII 18 , vegfr1 5′-ATATCGAACAT TCTCTTGGTCTTGC-3′, ApoB 5′-CAACTTAGTGTCCATTTTTATCGGC-3′ and apoA1 5′-TCAGTGCAAGAGCCACGAATTTCAT-3′ morpholino oligonucleotides (Gene Tools) were resuspended and injected as described 1 at concentrations of 5-20 ng per embryo. We injected pCS2vegfr1CDS mRNA (1,200 ng per embryo) and pCS2mtpCDS mRNA (232 ng per embryo) at the one-cell stage and the dome stage, respectively.
Microangiography and cell transplants. Microangiography was performed at 2.5 dpf, as described 42 . Intravascularly injected solutions were as follows: 1 µg µl −1 DiI-LDL (Invitrogen), 10 µM atorvastatin (Sigma) in DMSO, 6 µg ml −1 hexanoic acid (C 6 ) and 0.5 µg µl −1 human ApoB-100 (Meridian Life Science, A50220H) in PBS supplemented with 0.5% fattyacid-free BSA (Sigma, A8806). Human ApoB-100 is an artificially delipidated form of ApoB in which sodium deoxycholate is used to provide a stable environment for the ApoB protein to keep it in solution once the natural lipids are removed and to prevent its aggregation. The ApoB protein was solubilized in 0.5% fatty-acid-free BSA (Sigma, A8806), which renders it soluble in water 43 . HEK293 cells cotransfected with the plasmid Huh7MTP (encoding human MTP) and a plasmid encoding human ApoB34 (see below) or untransfected control cells were transplanted into the perivitelline space of one side of the yolk of 2.5 dpf stl; Tg(fli1:eGFP) yl mutant or WT embryos ventral to the developing SIVs 44 .
Microscopy and imaging. Zebrafish embryos used for imaging or in situ hybridization were treated with 0.003% phenylthiourea beginning at 8 hpf to inhibit melanin pigment formation. Confocal imaging was performed using a FV1000 Olympus imaging system or a Zeiss LSM780 upright confocal microscope equipped with X20 NA 1.0 lens, as described 1 .
Fatty-acid feeding of zebrafish embryos. We incubated dechorionized 24-hpf embryos with 6 µg ml −1 short-(hexanoic acid, Sigma, 12137), intermediate-(dodecanoic acid, Sigma, L4250) or long-chain fatty acid (oleic acid, Sigma, 01383) in embryo medium supplemented with 0.1% fatty-acid-free BSA (Sigma, A8806) for 48 h. Embryos were then fixed overnight in 4% paraformaldehyde and processed for alkaline phosphatase staining 45 .
Lipid content measurements. Triglyceride content measurements. We incubated dechorionized 24-hpf embryos with 2 µCi ml −1 [ 3 H]-oleic acid (Perkin Elmer NET289005MC) in a fatty-acid-free solution (Sigma, A8806) containing 0.1% BSA and 3 µg ml −1 oleic acid (Sigma, O1383) for 48 h. After deyolking, we homogenized the embryos in 1 ml cold methanol and extracted the lipids following the method of Bligh and Dyer 46 by adding ice-cold chloroform and double distilled water. We collected the lower chloroform phase, evaporated it under vacuum or N 2 and kept it at −20 °C. We developed the lipids on silica gel 60 thin-layer chromatography plates in a solvent system of petroleum ether, diethyl ether and acetic acid (80:20:1). Labeled lipids were visualized with autoradiography, and spots corresponding to the triglyceride standards (Sigma 17811) were scraped and quantified using liquid scintillation fluid. Cholesterol content measurements. For GC-MS, samples were lyophilized for 2 h, and 10 µl of pyridine and 80 µl of N-methyl-N-(trimethylsilyl)trifluoroacetamide were added to the dry residue. The samples were then shaken vigorously for 30 s, and the mixture was transferred to a 2-ml autosampler glass vial with a 100-ml conical glass insert. After capping the vial, the reaction mixture was incubated at room temperature for at least 1 h. The GC-MS instrument and analytical parameters used were as described by Itkin et al. 47 with some modification: the CT-split 1:25 mode was used here. Xcalibur software version 1.4 (Thermo Finnigan) was used for data analysis. Cholesterol present in the samples was identified as O-trimethylsilylcholesterol by a comparison of its retention time and mass spectrum for the sample mixture to those generated for the cholesterol authentic standard silylated as mentioned above, and analyzed using the same analytical parameters on the same instrument. The samples were injected in randomized order; the mix of alkanes, injected after each several biological samples, was utilized as quality control. The reconstructed ion chromatogram generated from the characteristic fragments of silylated cholesterol (329, 353, 368 and 458 Da) was used for the calculation of peak areas.
In situ hybridization and ORO and alkaline phosphatase staining. Embryos were fixed overnight in 4% paraformaldehyde and processed for alkaline phosphatase staining 45 , ORO staining 6 or whole-mount in situ hybridization using antisense mRNA probes for vegfr1, vegfr2, vegfr3 and cdh5, as described 48 .
Zebrafish western blot. Three-dpf zebrafish embryos were processed for western blot, as described 1 . VEGFR1 was detected using a 1:500 dilution of a custommade chick polyclonal serum (Aves Labs) generated against the peptide CZ TKD TDT KGR FSS PVL DVT EKQ. Blots were then reblocked by standard protocols and probed with a 1:5,000 dilution of antibody to tubulin (Sigma, T3526).
Fluorescence-activated cell sorting (FACS) of endothelial cells from zebrafish embryos. We used 3-dpf Tg(fli1:eGFP) yl embryos for FACS of GFP-labeled endothelial cells. Single-cell suspensions were prepared as described in Takada et al. 49 . Sorting was performed at 4 °C in a FACSAria cell sorter using a 70-µm nozzle. GFP + and GFP − cells were separately collected in 1 ml FCS. Sorted cells were washed with PBS and centrifuged at 300 g at 4 °C for 5 min twice. The cell pellet was suspended in 1 ml TRIzol for RNA extraction. npg imaged. The total length of the interface between the endothelial and transplanted cells (Supplementary Fig. 6 , blue = L1), as well as the total length of overlap between the two cell populations (Supplementary Fig. 6 , yellow = L2), was traced and measured. The ratio r = L2/(L1 + L2) was used to measure the ability of endothelial cells to migrate over the ApoB-secreting cells.
Mice and immunofluorescence.
Apoe-and Ldlr-null mice (Jackson Laboratory) in the C57BL/6 background and the corresponding WT C57BL/6 controls (Jackson Laboratory) were handled according to the Weizmann Institute Animal Care and Use Committee. All analyses were performed using mice at 8-38 weeks of age fed with a normal chow diet. After anesthesia, the aortas of the mice were dissected and frozen for further PCR analyses or fixed for 3 h in 4% paraformaldehyde, equilibrated for 36 h in 30% sucrose in PBS-Tween, embedded in Tissue-Tek O.C.T. Compound (4583) and frozen at −80 °C. Slides of 7-µm sections were fixed in cold methanol, blocked with BSA and goat serum and stained overnight with antibody to CD31 (BD, 550274, 1:100) and antibody to VEGFR1 (Abcam, AB2350, 1:100). Slides were then incubated for 2 h with Cy3 anti-rabbit (Jackson, 111-485-045, 1:100) and Cy2 anti-rat antibodies (Jackson, 112-505-003, 1:100), stained with DAPI (10 mM InnoTrain Diagnostik) and mounted in fluorescent mounting medium. Images were captured using a Zeiss LSM780 confocal microscope.
RNA isolation from mouse aortic tissue and RT-PCR analyses. We homogenized dissected aortas from C57BL/6 and Apoe-null mice (500 mg of tissue per sample) in TRIzol and processed them for RNA isolation and semiquantitative PCR, as described 53 . For all samples, cDNA was generated from equal amounts of RNA (600 ng).
To measure the relative changes in Vegfr1 mRNA transcripts, we used the following primers: 5′-GGCCCGGGATATTTATAAGAAC-3′ and 5′-CCAT CCATTTTAGGGGAAGTC-3′. Expression levels were standardized to the primer set specific for b2-microglobulin: 5′-GTCTCGATCCCAGTAGA CGG-3′ and 5′-TGGTGCTTGTCTCACTGACC-3′. Quantitative analyses were performed using ImageJ.
Statistical analyses.
Error bars of mean data points are ± s.e.m. Comparisons of two populations were done with unpaired two-tailed t tests assuming unequal variance of the populations (Figs. 1,3 and 4) . Comparison of multiple populations was done using one-way analysis of variance (ANOVA) (Fig. 2) . Testing whether two populations are drawn from identical distributions was done using the χ 2 test (Fig. 2) . To compute significance for the difference between two values, each representing a mean of a population, we tested the deviation of the ratio between them from 1 using a two-tailed z test (Fig. 3) . All statistical tests were performed in Matlab. We used the ttest2 function for t test and the anova1 function for ANOVA. We relied on the function normcdf to perform the z test and on the function chi2cdf to perform the χ 2 test.
